Robert C Goeltz II's Net Worth
Robert C Goeltz II's net worth is estimated to be at least $668,929.07 as of 05/19/2024. CoreStreet's estimation of Robert C Goeltz II's net worth is based on their sale of stock and current holding of stock.
Robert C Goeltz II is CFO at Arcus Biosciences Inc. They have executed at least 5 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,004 units of RCUS stock on 01/02/2024. Their biggest sale was on 03/20/2017 when they sold 21,517 units of CytomX Therapeutics Inc stock for $426,251.77. They typically trade 1 times per year.
Total value of insider buys:
- $107,850.00
Total value of insider sells:
- $561,079.07
Most recent insider trade:
- Jan. 2, 2024
Robert C Goeltz II's Insider Trading History
| Arcus Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 2, 2024 | CFO | 2,004 | $20.00 | Sell | $40,080.00 |
Dec. 16, 2022 | CFO | 2,453 | $30.75 | Sell | $75,429.75 |
Dec. 16, 2021 | CFO | 485 | $39.83 | Sell | $19,317.55 |
Sept. 9, 2020 | CFO | 5,000 | $21.57 | Buy | $107,850.00 |
| CytomX Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 20, 2017 | CFO | 21,517 | $19.81 | Sell | $426,251.77 |